ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF05 | BioTech | Atezolizumab - 1200mg | 10381 | 181919/1 | TECENTRIQ | 1200mg | 1 | Injectable concentrate for solution | Infusion | Omnipharma | F. Hoffmann La Roche Ltd, Kaiseraugst | Switzerland | 384,573,023 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF05 | BioTech | Atezolizumab - 1200mg | 8901 | 182416/1 | TECENTRIQ | 1200mg | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 384,573,023 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
L01FF05 | BioTech | Atezolizumab - 1200mg | 10381/388 | 181919/1 | TECENTRIQ | 1200mg | 1 | Injectable concentrate for solution | Infusion | Omnipharma | F. Hoffmann La Roche Ltd, Kaiseraugst | Switzerland | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 |